您当前的位置：
首页 >
文章列表页 >
Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis
Article | 更新时间：2026-02-09

    • Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis

    • “Experts from Wuxi Second People's Hospital conducted a retrospective analysis of lung cancer patients who underwent surgical resection from 2016 to 2023, providing a basis for clinical differentiation of SMARCA4 deficient poorly differentiated NSCLC and SD-UT, and predicting their prognosis.”
    • China Oncology   Vol. 35, Issue 12, Pages: 1108-1118(2025)

    • DOI：10.19401/j.cnki.1007-3639.2025.12.003    

      CLC： R734.2

    • Received：08 April 2025，

      Revised：2025-10-19，

      Published：30 December 2025

    移动端阅览

  • CHANG Kesheng, SHAO Jin, ZHANG Qi, et al. Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis[J]. China Oncology, 2025, 35(12): 1108-1118. DOI： 10.19401/j.cnki.1007-3639.2025.12.003.

  •  
  •  

0

Views

7

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Investigation of flow cytometry in bone marrow involvement and prognostic prediction of mantle cell lymphoma
Advances in gastric mucosal-associated lymphoid tissue lymphoma
Treatment strategies and prognostic analysis of 87 patients with salivary duct carcinoma: a retrospective cohort study
Impact of radiation-induced lymphopenia on prognosis in patients with limited-stage small cell lung cancer: a cohort study
MITF expression in acral melanoma tissues and its association with clinical, pathological characteristics and prognosis

Related Author

WANG Di
LI Menghan
WU Haochen
SUN Jinmiao
XIE Ziteng
LI Jiwei
ZHANG Lei
ZHANG Mingzhi

Related Institution

Department of Oncology, The First Affiliated Hospital of Zhengzhou University
Department of Medical Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Malignant Tumors
0